Ionsys

RSS

Withdrawn

This medicine's authorisation has been withdrawn

fentanyl
MedicineHumanWithdrawn

Icelandic is available via eTranslation, the European Commission's machine translation service.

Translate to Icelandic | Important information about machine translation

  • Application under evaluation
  • CHMP opinion
  • European Commission decision

Overview

On 27 September 2018 the European Commission withdrew the marketing authorisation for Ionsys (fentanyl) in the European Union (EU). The withdrawal was at the request of the marketing authorisation holder, Incline Therapeutics Europe Ltd, which notified the European Commission of its decision to permanently discontinue the marketing of the product for commercial reasons. 

Ionsys was granted marketing authorisation in the EU on 19 November 2015 for treatment of acute moderate to severe post-operative pain. 

The European Public Assessment Report (EPAR) for Ionsys is updated accordingly to reflect the fact that the marketing authorisation is no longer valid.

български (BG) (622.86 KB - PDF)

Skoða

español (ES) (545.72 KB - PDF)

Skoða

čeština (CS) (606.8 KB - PDF)

Skoða

dansk (DA) (78.75 KB - PDF)

Skoða

Deutsch (DE) (81.28 KB - PDF)

Skoða

eesti (ET) (79.01 KB - PDF)

Skoða

ελληνικά (EL) (627.93 KB - PDF)

Skoða

français (FR) (81.05 KB - PDF)

Skoða

hrvatski (HR) (96.17 KB - PDF)

Skoða

italiano (IT) (79.71 KB - PDF)

Skoða

latviešu (LV) (604.16 KB - PDF)

Skoða

lietuvių (LT) (566.53 KB - PDF)

Skoða

magyar (HU) (547.89 KB - PDF)

Skoða

Malti (MT) (607.9 KB - PDF)

Skoða

Nederlands (NL) (545.31 KB - PDF)

Skoða

polski (PL) (603.26 KB - PDF)

Skoða

português (PT) (80.28 KB - PDF)

Skoða

română (RO) (96.65 KB - PDF)

Skoða

slovenčina (SK) (604.16 KB - PDF)

Skoða

slovenščina (SL) (596.95 KB - PDF)

Skoða

suomi (FI) (543.59 KB - PDF)

Skoða

svenska (SV) (545.77 KB - PDF)

Skoða

Product information

български (BG) (2.4 MB - PDF)

Skoða

español (ES) (1.44 MB - PDF)

Skoða

čeština (CS) (916.67 KB - PDF)

Skoða

dansk (DA) (1.48 MB - PDF)

Skoða

Deutsch (DE) (843.28 KB - PDF)

Skoða

eesti (ET) (1.42 MB - PDF)

Skoða

ελληνικά (EL) (2.36 MB - PDF)

Skoða

français (FR) (815.82 KB - PDF)

Skoða

hrvatski (HR) (983.27 KB - PDF)

Skoða

italiano (IT) (808.11 KB - PDF)

Skoða

latviešu (LV) (2.12 MB - PDF)

Skoða

lietuvių (LT) (967.88 KB - PDF)

Skoða

magyar (HU) (2.7 MB - PDF)

Skoða

Malti (MT) (2.04 MB - PDF)

Skoða

Nederlands (NL) (1.39 MB - PDF)

Skoða

polski (PL) (2.16 MB - PDF)

Skoða

português (PT) (833.76 KB - PDF)

Skoða

română (RO) (1.62 MB - PDF)

Skoða

slovenčina (SK) (969.53 KB - PDF)

Skoða

slovenščina (SL) (2.03 MB - PDF)

Skoða

suomi (FI) (1.35 MB - PDF)

Skoða

svenska (SV) (732.48 KB - PDF)

Skoða

Íslenska (IS) (1.41 MB - PDF)

Skoða

norsk (NO) (805.06 KB - PDF)

Skoða
26/10/2018
icon globe

This medicine’s product information is available in all official EU languages.
Select 'available languages' to access the language you need.

 

Product information documents contain:

  • summary of product characteristics (annex I);
  • manufacturing authorisation holder responsible for batch release (annex IIA);
  • conditions of the marketing authorisation (annex IIB);
  • labelling (annex IIIA);
  • package leaflet (annex IIIB).

български (BG) (535.66 KB - PDF)

Skoða

español (ES) (460.94 KB - PDF)

Skoða

čeština (CS) (503 KB - PDF)

Skoða

dansk (DA) (470.75 KB - PDF)

Skoða

Deutsch (DE) (453.7 KB - PDF)

Skoða

eesti (ET) (468.58 KB - PDF)

Skoða

ελληνικά (EL) (530.46 KB - PDF)

Skoða

français (FR) (458.28 KB - PDF)

Skoða

hrvatski (HR) (485.32 KB - PDF)

Skoða

magyar (HU) (499.13 KB - PDF)

Skoða

Malti (MT) (531.06 KB - PDF)

Skoða

Nederlands (NL) (470.97 KB - PDF)

Skoða

polski (PL) (521.84 KB - PDF)

Skoða

português (PT) (453.82 KB - PDF)

Skoða

slovenčina (SK) (482.02 KB - PDF)

Skoða

slovenščina (SL) (514.9 KB - PDF)

Skoða

suomi (FI) (468.32 KB - PDF)

Skoða

svenska (SV) (453.78 KB - PDF)

Skoða

Íslenska (IS) (468.49 KB - PDF)

Skoða

Product details

Name of medicine
Ionsys
Active substance
fentanyl hydrochloride
International non-proprietary name (INN) or common name
fentanyl
Therapeutic area (MeSH)
Pain, Postoperative
Anatomical therapeutic chemical (ATC) code
N02AB03

Pharmacotherapeutic group

Analgesics

Therapeutic indication

Ionsys is indicated for the management of acute moderate to severe post-operative pain in adult patients.

Authorisation details

EMA product number
EMEA/H/C/002715
Marketing authorisation holder
Incline Therapeutics Europe Ltd

21 St Thomas Street
Bristol
BS1 6JS
United Kingdom

Opinion adopted
23/09/2015
Marketing authorisation issued
18/11/2015
Withdrawal of marketing authorisation
27/09/2018
Revision
2

Assessment history

This page was last updated on

Share this page